| Solidification to improve the biopharmaceutical performance of SEDDS: Opportunities and challenges P Joyce, TJ Dening, TR Meola, HB Schultz, R Holm, N Thomas, ... Advanced drug delivery reviews 142, 102-117, 2019 | 98 | 2019 |
| Novel nanostructured solid materials for modulating oral drug delivery from solid-state lipid-based drug delivery systems TJ Dening, S Rao, N Thomas, CA Prestidge The AAPS journal 18, 23-40, 2016 | 71 | 2016 |
| Oral nanomedicine approaches for the treatment of psychiatric illnesses TJ Dening, S Rao, N Thomas, CA Prestidge Journal of Controlled Release 223, 137-156, 2016 | 56 | 2016 |
| Supersaturation potential of ordered mesoporous silica delivery systems. Part 1: Dissolution performance and drug membrane transport rates TJ Dening, LS Taylor Molecular Pharmaceutics 15 (8), 3489-3501, 2018 | 44 | 2018 |
| Nanostructured montmorillonite clay for controlling the lipase-mediated digestion of medium chain triglycerides TJ Dening, P Joyce, S Rao, N Thomas, CA Prestidge ACS applied materials & interfaces 8 (48), 32732-32742, 2016 | 41 | 2016 |
| Silica encapsulated lipid-based drug delivery systems for reducing the fed/fasted variations of ziprasidone in vitro TJ Dening, S Rao, N Thomas, CA Presidge European Journal of Pharmaceutics and Biopharmaceutics, 2016 | 36 | 2016 |
| Application of an adsorption isotherm to explain incomplete drug release from ordered mesoporous silica materials under supersaturating conditions TJ Dening, D Zemlyanov, LS Taylor Journal of controlled release 307, 186-199, 2019 | 31 | 2019 |
| Montmorillonite-lipid hybrid carriers for ionizable and neutral poorly water-soluble drugs: Formulation, characterization and in vitro lipolysis studies TJ Dening, S Rao, N Thomas, CA Prestidge International Journal of Pharmaceutics 526 (1-2), 95-105, 2017 | 30 | 2017 |
| Montmorillonite and Laponite clay materials for the solidification of lipid-based formulations for the basic drug Blonanserin: in vitro and in vivo investigations TJ Dening, N Thomas, S Rao, C Van Looveren, F Cuyckens, R Holm, ... Molecular pharmaceutics 15 (9), 4148-4160, 2018 | 24 | 2018 |
| Spray dried smectite clay particles as a novel treatment against obesity TJ Dening, P Joyce, M Kovalainen, H Gustafsson, CA Prestidge Pharmaceutical Research 36, 1-14, 2019 | 17 | 2019 |
| Improving correlations between drug solubilization and in vitro lipolysis by monitoring the phase partitioning of lipolytic species for lipid-based formulations TJ Dening, P Joyce, CA Prestidge Journal of Pharmaceutical Sciences 108 (1), 295-304, 2019 | 16 | 2019 |
| Inorganic surface chemistry and nanostructure controls lipolytic product speciation and partitioning during the digestion of inorganic-lipid hybrid particles TJ Dening, P Joyce, JL Webber, DA Beattie, CA Prestidge Journal of colloid and interface science 532, 666-679, 2018 | 16 | 2018 |
| Nanocrystal-silica-lipid hybrid particles for the improved oral delivery of ziprasidone in vitro TR Meola, TJ Dening, CA Prestidge European Journal of Pharmaceutics and Biopharmaceutics 129, 145-153, 2018 | 16 | 2018 |
| Modulating the Lipase‐Mediated Bioactivity of Particle‐Lipid Conjugates Through Changes in Nanostructure and Surface Chemistry P Joyce, TJ Dening, H Gustafsson, CA Prestidge European journal of lipid science and technology 119 (12), 1700213, 2017 | 12 | 2017 |
| Nanostructured clay particles supplement orlistat action in inhibiting lipid digestion: An in vitro evaluation for the treatment of obesity P Joyce, TJ Dening, TR Meola, H Gustafsson, M Kovalainen, ... European Journal of Pharmaceutical Sciences 135, 1-11, 2019 | 11 | 2019 |
| Contrasting anti-obesity effects of smectite clays and mesoporous silica in Sprague-Dawley rats P Joyce, TJ Dening, TR Meola, A Wignall, H Ulmefors, M Kovalainen, ... ACS Applied Bio Materials 3 (11), 7779-7788, 2020 | 8 | 2020 |
| In vitro performance and chemical stability of lipid-based formulations encapsulated in a mesoporous magnesium carbonate carrier C Alvebratt, TJ Dening, M Åhlén, O Cheung, M Strømme, A Gogoll, ... Pharmaceutics 12 (5), 426, 2020 | 7 | 2020 |
| Do Macrocyclic Peptide Drugs Interact with Bile Salts under Simulated Gastrointestinal Conditions? TJ Dening, JT Douglas, MJ Hageman Molecular Pharmaceutics 18 (8), 3086-3098, 2021 | 5 | 2021 |
| Biorelevant dissolution method considerations for the appropriate evaluation of amorphous solid dispersions: are two stages necessary? Z Wang, H Lou, TJ Dening, MJ Hageman Journal of Pharmaceutical Sciences 112 (4), 1089-1107, 2023 | 4 | 2023 |
| Enhancing intestinal absorption of a model macromolecule via the paracellular pathway using E-Cadherin peptides TJ Dening, TJ Siahaan, MJ Hageman Journal of Pharmaceutical Sciences 110 (5), 2139-2148, 2021 | 2 | 2021 |
Clive PrestidgeProfessor, Co-Director Centre for Pharmaceutical Innovation,University of South AustraliaVerified email at unisa.edu.au
